Loading...
Type III–IV muscle afferents are not required for steady-state exercise hyperpnea in healthy subjects and patients with COPD or heart failure
Blockade of group III–IV muscle afferents by intrathecal injection of the μ-opioid agonist fentanyl (IF) in humans has been variously reported to depress exercise hyperpnea in some studies but not others. A key unanswered question is whether such an effect is transient or persists in the steady stat...
Na minha lista:
| Udgivet i: | Respir Physiol Neurobiol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4575501/ https://ncbi.nlm.nih.gov/pubmed/25911558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.resp.2015.04.007 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|